Literature DB >> 18022824

Regulation of placental villous angiopoietin-1 and -2 expression by estrogen during baboon pregnancy.

Eugene D Albrecht1, Jeffery S Babischkin, Gerald J Pepe.   

Abstract

We recently showed an increase in vascular endothelial growth factor (VEGF), decrease in angiopoietin-1 (Ang-1) and unaltered Ang-2 expression by the villous placenta with advancing baboon pregnancy. Moreover, placental VEGF expression was increased by estrogen in early pregnancy. In the present study, we determined whether placental Ang-1 and Ang-2 are regulated by estrogen. Ang-1 and Ang-2 mRNA and protein were determined by RT-PCR and immunocytochemistry in the placenta of baboons on Day 60 of gestation (term is 184 days) after administration of estrogen precursor androstenedione on Days 25-59 or on Day 54 after acute estradiol administration. Chronic androstenedione treatment increased serum estradiol levels three-fold (P < 0.001) and decreased (P < 0.05) villous cytotrophoblast Ang-1 mRNA to a level (0.36 +/- 0.08 relative to 18S rRNA) that was one-third of that in untreated animals (0.98 +/- 0.26). Within 2 hr of estradiol administration, cytotrophoblast Ang-1 mRNA was decreased to a level (0.24 +/- 0.05) one-fifth (P < 0.05) of that in untreated animals (1.14 +/- 0.23). However, Ang-2 mRNA levels were unaltered. Ang-1, Ang-2 and estrogen receptors alpha and beta protein were localized within villous cytotrophoblasts providing a mechanism for estrogen action at this site. In summary, estrogen increased VEGF, decreased Ang-1, and had no effect on Ang-2 expression within placental cytotrophoblasts during early baboon pregnancy. We propose that the estrogen-dependent differential regulation of these angioregulatory factors underpins the unique pattern of neovascularization established within the villous placenta during primate pregnancy. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18022824      PMCID: PMC2689619          DOI: 10.1002/mrd.20721

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  38 in total

1.  Regulation of angiopoietin and Tie-2 receptor expression in non-reproductive tissues by estrogen.

Authors:  Fencheng Ye; Maria Florian; Sheldon A Magder; Sabah N A Hussain
Journal:  Steroids       Date:  2002-03       Impact factor: 2.668

2.  Developmental regulation of vascular endothelial growth/permeability factor messenger ribonucleic acid levels in and vascularization of the villous placenta during baboon pregnancy.

Authors:  V A Hildebrandt; J S Babischkin; R D Koos; G J Pepe; E D Albrecht
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

Review 3.  Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy.

Authors:  P Kaufmann; T M Mayhew; D S Charnock-Jones
Journal:  Placenta       Date:  2004 Feb-Mar       Impact factor: 3.481

4.  Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

Authors:  Richard P Visconti; Charlene D Richardson; Thomas N Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

5.  The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae.

Authors:  E G Zhang; S K Smith; P N Baker; D S Charnock-Jones
Journal:  Mol Med       Date:  2001-09       Impact factor: 6.354

6.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.

Authors:  Ivan B Lobov; Peter C Brooks; Richard A Lang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

Review 7.  Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation.

Authors:  D S Charnock-Jones; P Kaufmann; T M Mayhew
Journal:  Placenta       Date:  2004 Feb-Mar       Impact factor: 3.481

8.  Localized expression of angiopoietin 1 and 2 may explain unique characteristics of the rat testicular microvasculature.

Authors:  Stina Häggström Rudolfsson; Anna Johansson; Ingela Franck Lissbrant; Pernilla Wikström; Anders Bergh
Journal:  Biol Reprod       Date:  2003-05-28       Impact factor: 4.285

9.  Expressional regulation of the angiopoietin-1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: a study of adrenocorticotropin-induced repair.

Authors:  Olivier Féraud; Christine Mallet; Isabelle Vilgrain
Journal:  Endocrinology       Date:  2003-06-19       Impact factor: 4.736

Review 10.  Angiogenesis during primate placentation in health and disease.

Authors:  Christine Wulff; Melanie Weigand; Rolf Kreienberg; Hamish M Fraser
Journal:  Reproduction       Date:  2003-11       Impact factor: 3.906

View more
  4 in total

Review 1.  Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy.

Authors:  Eugene D Albrecht; Gerald J Pepe
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

2.  Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation.

Authors:  Amanda K Hurliman; Leon Speroff; Richard L Stouffer; Phillip E Patton; Annette Lee; Theodore A Molskness
Journal:  Fertil Steril       Date:  2009-05-23       Impact factor: 7.329

3.  Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.

Authors:  Hyun Ho Han; Baek Gil Kim; Joo Hyun Lee; Suki Kang; Ji Eun Kim; Nam Hoon Cho
Journal:  Endocr Relat Cancer       Date:  2016-06-27       Impact factor: 5.678

4.  Role of mouse Wdr13 in placental growth; a genetic evidence for lifetime body weight determination by placenta during development.

Authors:  Vijay Pratap Singh; Jomini Liza Alex; B Jyothi Lakshmi; S Purnima Sailasree; T Avinash Raj; Satish Kumar
Journal:  Sci Rep       Date:  2015-08-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.